Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
A Decade of Disproport
Co-Investigator
Descriptive epidemiolo
Gorvine, Margaret
Losartan decreases p42
See All (5) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression.
Ararat E, Brozovich FV. Losartan decreases p42/44 MAPK signaling and preserves LZ+ MYPT1 expression. PLoS One. 2009; 4(4):e5144.
View in:
PubMed
subject areas
Angiotensin II Type 1 Receptor Blockers
Angiotensin-Converting Enzyme Inhibitors
Animals
Aorta
Captopril
Enzyme Activation
Heart Failure
Humans
Isoenzymes
Losartan
Male
MAP Kinase Signaling System
Mitogen-Activated Protein Kinase 1
Mitogen-Activated Protein Kinase 3
Muscle, Smooth, Vascular
Myocardial Infarction
p38 Mitogen-Activated Protein Kinases
Protein Phosphatase 1
Rats
Rats, Sprague-Dawley
Ventricular Function, Left
authors with profiles
Erhan Ararat